🚀 VC round data is live in beta, check it out!

🩺

Multiples Medical Devices Index

Curated by Multiples, this index tracks the largest medical device companies globally.

Explore the Multiples Medical Devices Index

100

public companies tracked

$4.4T

cumulative enterprise value

4.2x

median EV/NTM revenue multiple

7%

median NTM/LTM revenue growth

Index Performance

This chart shows the weighted market cap evolution over time for the Multiples Medical Devices Index constituents, indexed to 0% at the beginning of the period.

+0.0%

Multiples Medical Devices Index

Data as of 01 April 2026. Underlying financial data from FactSet and Morningstar. S&P 500 and NASDAQ data sourced from Yahoo Finance.

Key Index Metrics

This chart shows the median evolution over time of key valuation metrics for the Multiples Medical Devices Index constituents.

Valuation Benchmarks

This chart shows the regression relationship between valuation metrics across companies in the Multiples Medical Devices Index.

x-axis:
y-axis:

Data as of April 1, 2026. Companies with EV multiples above 50x and y-axis values above 250% are considered non-meaningful and excluded from calculation.

Company Rankings

This chart shows company rankings by selected metric within the Multiples Medical Devices Index.

Metric:

Data as of April 1, 2026. Companies with EV multiples above 50x and y-axis values above 300% are considered non-meaningful and excluded from calculation.

Companies Side-by-Side

Compare key metrics between companies in the Multiples Medical Devices Index.

1:
2:
3:
Metric
Samsung
Johnson & Johnson
Roche
Market Cap
$916B
$577B
$377B
EV/Revenue (NTM)
2.3x
5.9x
5.1x
EV/Gross Profit (NTM)
3.9x
8.3x
6.8x
EV/EBITDA (NTM)
4.7x
15.7x
12.6x
EV/FCF (NTM)
9.1x
23.7x
21.4x
Revenue Growth
38%
7%
-1%
Gross Margin (NTM)
60%
72%
75%
EBITDA Margin (NTM)
50%
38%
40%
FCF Margin (NTM)
26%
25%
24%
Rule of 40
108%
44%
39%
Rule of X
197%
55%
37%

Data as of April 1, 2026.

Cumulative Metrics

This chart shows the cumulative sum of selected metrics across all companies in the Multiples Medical Devices Index, over time.

Index Methodology

Similar to the NASDAQ 100 Index, the Multiples Medical Devices Index employs a modified market capitalization weighting scheme.

The weight process uses company-level weights, which are derived using company market capitalization.

Company weights are evaluated based on two rules:

Rule 1

No company's weight may exceed 24%.

Rule 2

The aggregate weight of the companies whose weights exceed 4.5% may not exceed 48%.

If neither rule is 'violated', then no adjustments are made. Only in cases where either or both of the rules are 'violated', weight adjustments are made according to a two-stage adjustment process.

Rule 1 adjustment

If no company's initial weight exceeds 24% of the Index, initial weights are used as Rule 1 weights without adjustment. Otherwise, initial weights are adjusted such that no company's weight may exceed 20% of the Index.

Rule 2 adjustment

If the aggregate weight of the companies whose Rule 1 weights exceeds 4.5% and does not exceed 48%, Rule 1 weights are used as the final weights. Otherwise, Rule 1 weights are adjusted such that:

  • The aggregate weight of the companies whose Rule 1 weights exceeded 4.5% is set to 40%.
  • Companies with Rule 1 weights below 4.5% may also have their weights adjusted to keep the initial rank order of all companies.

If the two-stage rule process results in a 'violation' of the weighting rules as previously detailed, then the process is repeated until the company weights meet the rule system.

Companies Included in the Multiples Medical Devices Index

This index tracks the largest publicly listed medical device companies across diagnostics, surgical equipment, implantable technologies, and more.

KR
14.9%
$137
+274%
$916B
2.3x
38%
60%
50%
26%
108%
$2M
US
9.4%
$240
+53%
$577B
5.9x
7%
72%
38%
25%
44%
$682K
CH
6.1%
$59
+43%
$377B
5.1x
-1%
75%
40%
24%
39%
$710K
DE
3.3%
$260
+11%
$202B
2.5x
5%
39%
19%
11%
24%
$289K
US
3.2%
$114
-13%
$198B
4.1x
9%
57%
27%
19%
36%
$385K
US
3.1%
$509
+19%
$191B
4.6x
5%
42%
26%
16%
31%
$356K
US
6.1%
$496
-4%
$176B
14.3x
14%
67%
43%
34%
57%
$591K
US
5.1%
$387
+4%
$148B
5.7x
9%
65%
29%
16%
38%
$449K
US
5.0%
$206
+3%
$146B
6.2x
5%
60%
32%
23%
36%
$409K
US
4.3%
$98
+16%
$126B
3.8x
7%
65%
29%
18%
36%
$353K
US
3.9%
$76
-26%
$113B
5.4x
11%
70%
32%
17%
42%
$340K
DE
1.8%
$47
-13%
$53B
1.8x
4%
40%
21%
10%
24%
$363K
US
1.7%
$637
+47%
$51B
10.8x
9%
62%
36%
24%
44%
$391K
US
1.7%
$87
+15%
$51B
6.9x
10%
79%
32%
23%
42%
$379K
CH
1.4%
$85
-12%
$41B
4.1x
5%
61%
27%
15%
30%
$401K
US
1.2%
$25
-5%
$36B
6.0x
8%
62%
40%
28%
48%
$486K
US
1.2%
$79
+12%
$36B
1.9x
5%
41%
19%
8%
24%
$382K
US
1.1%
$118
+10%
$33B
4.6x
7%
54%
30%
18%
36%
$384K
CN
1.1%
$27
-16%
$33B
5.5x
9%
61%
35%
30%
45%
$226K
US
1.0%
$307
-12%
$30B
4.7x
65%
57%
32%
17%
134%
$401K
NL
1.0%
$30
+17%
$29B
1.7x
-1%
46%
17%
8%
18%
$317K
US
1.0%
$74
+3%
$28B
5.2x
12%
64%
31%
21%
43%
$420K
US
0.9%
$1,325
+24%
$27B
6.8x
5%
60%
32%
22%
36%
$222K
US
0.8%
$248
+10%
$24B
4.1x
6%
44%
27%
34%
$307K
GB
0.7%
$54
+47%
$21B
5.7x
11%
42%
25%
15%
37%
$338K
US
0.7%
$133
+71%
$20B
4.6x
5%
68%
29%
17%
33%
$431K
US
0.7%
$206
-13%
$20B
6.0x
6%
48%
31%
12%
39%
$342K
US
0.7%
$99
-3%
$19B
3.1x
4%
71%
32%
16%
36%
$484K
DK
0.6%
$8
-33%
$17B
4.5x
6%
68%
32%
18%
37%
$250K
US
0.6%
$243
-4%
$17B
5.0x
22%
72%
24%
13%
46%
$502K
US
0.6%
$75
+30%
$17B
3.9x
4%
59%
33%
24%
36%
$580K
US
0.5%
$82
+0%
$16B
4.2x
5%
67%
32%
15%
38%
$273K
CN
0.5%
$18
-6%
$15B
5.8x
20%
48%
18%
10%
38%
$182K
GB
0.5%
$17
+23%
$15B
2.6x
7%
70%
27%
11%
33%
$355K
CH
0.5%
$239
-26%
$14B
2.9x
3%
71%
26%
17%
28%
$269K
NZ
0.5%
$24
+18%
$14B
9.5x
11%
65%
35%
17%
56%
$160K
US
0.5%
$189
+9%
$14B
3.0x
4%
71%
28%
21%
31%
$193K
US
0.5%
$342
+17%
$13B
8.0x
13%
69%
20%
11%
33%
$299K
US
0.4%
$457
+48%
$13B
4.4x
10%
29%
22%
20%
33%
$408K
DE
0.4%
$46
-11%
$13B
1.0x
-2%
26%
18%
9%
18%
$211K
US
0.4%
$73
+10%
$13B
2.0x
-1%
55%
27%
5%
25%
$378K
US
0.4%
$94
+31%
$13B
3.8x
8%
70%
33%
13%
42%
$490K
US
0.3%
$20
-37%
$10B
1.6x
1%
37%
18%
9%
19%
$300K
JP
0.3%
$9
-22%
$10B
1.6x
5%
65%
20%
6%
23%
$227K
IN
0.3%
$10
+1%
$10B
3.3x
9%
71%
24%
13%
35%
$97K
US
0.3%
$175
+9%
$9B
5.7x
7%
62%
29%
13%
23%
$177K
AU
0.3%
$134
-31%
$9B
4.9x
9%
74%
26%
16%
33%
$292K
JP
0.3%
$26
+14%
$8B
1.8x
7%
46%
17%
1%
24%
$226K
US
0.3%
$278
+15%
$7B
2.8x
2%
57%
18%
15%
19%
$347K
US
0.2%
$121
+29%
$7B
10.5x
23%
85%
5%
8%
24%
$464K
CA
0.2%
$18
+66%
$6B
2.1x
5%
62%
19%
9%
23%
$392K
CN
0.2%
$21
-16%
$6B
14.2x
13%
92%
60%
50%
73%
$291K
DK
0.2%
$30
-18%
$6B
2.3x
8%
76%
24%
10%
35%
$136K
GB
0.2%
$3
-7%
$6B
3.0x
6%
61%
27%
11%
32%
$233K
IN
0.2%
$280
-13%
$6B
7.2x
9%
47%
28%
20%
37%
$204K
CN
0.2%
$8
-1%
$6B
6.9x
15%
70%
44%
36%
59%
$231K
US
0.2%
$38
-4%
$6B
2.0x
4%
51%
19%
6%
23%
$354K
US
0.2%
$21
$6B
5.2x
24%
66%
17%
8%
40%
$459K
JP
0.2%
$9
-45%
$6B
1.7x
7%
51%
22%
5%
27%
$307K
SE
0.2%
$21
+3%
$6B
1.7x
-5%
50%
20%
9%
19%
$336K
US
0.2%
$23
+41%
$6B
5.5x
18%
47%
26%
15%
49%
$282K
JP
0.2%
$131
+114%
$6B
2.2x
3%
22%
10%
27%
$243K
CN
0.2%
$5
+10%
$5B
3.1x
13%
50%
21%
34%
$172K
US
0.2%
$123
-10%
$5B
3.4x
12%
62%
25%
24%
39%
$141K
JP
0.2%
$20
+46%
$5B
5.4x
9%
69%
35%
18%
48%
$85K
US
0.2%
$147
+60%
$5B
6.6x
21%
60%
22%
12%
43%
$674K
US
0.2%
$141
+18%
$5B
4.6x
7%
46%
24%
16%
30%
$327K
US
0.2%
$29
+83%
$5B
1.8x
4%
56%
14%
10%
19%
$227K
CN
0.2%
$34
-19%
$5B
9.1x
26%
74%
40%
21%
66%
CN
0.2%
$3
+58%
$5B
4.4x
14%
65%
29%
44%
$2M
CH
0.2%
$344
-23%
$5B
5.7x
-3%
47%
46%
-5%
43%
$340K
JP
0.2%
$44
+37%
$5B
0.8x
-1%
33%
11%
5%
13%
$213K
US
0.2%
$77
-19%
$5B
3.0x
6%
52%
25%
14%
31%
$202K
US
0.1%
$128
+20%
$4B
4.7x
17%
72%
13%
8%
29%
$311K
DE
0.1%
$65
$4B
2.6x
5%
56%
26%
12%
31%
GB
0.1%
$55
+85%
$4B
3.6x
5%
46%
23%
11%
29%
$181K
US
0.1%
$14
$4B
1.2x
56%
16%
1%
25%
$339K
CH
0.1%
$200
+18%
$4B
4.4x
13%
28%
6%
41%
$411K
CN
0.1%
$9
-18%
$4B
7.4x
14%
53%
14%
25%
SE
0.1%
$20
-37%
$4B
9.7x
16%
84%
26%
16%
38%
$262K
US
0.1%
$70
+90%
$4B
2.4x
7%
68%
23%
12%
30%
$479K
JP
0.1%
$13
+55%
$4B
2.6x
4%
49%
20%
7%
26%
$215K
US
0.1%
$81
$4B
7.7x
39%
69%
13%
5%
54%
US
0.1%
$142
+4%
$4B
2.1x
0%
41%
19%
17%
$172K
IT
0.1%
$15
-24%
$3B
1.7x
5%
83%
23%
10%
26%
$185K
DK
0.1%
$12
-33%
$3B
3.0x
10%
61%
19%
9%
28%
$185K
CN
0.1%
$5
-6%
$3B
4.2x
10%
65%
38%
31%
48%
$112K
US
0.1%
$86
-32%
$3B
2.3x
1%
27%
22%
6%
21%
$163K
US
0.1%
$64
+1%
$3B
2.8x
5%
60%
31%
21%
34%
$450K
CN
0.1%
$5
+106%
$3B
8.1x
23%
42%
24%
48%
CN
0.1%
$7
+28%
$3B
5.8x
17%
71%
CN
0.1%
$6
+9%
$3B
DE
0.1%
$30
-57%
$3B
1.0x
2%
53%
16%
6%
18%
$543K
CN
0.1%
$1
+52%
$3B
2.6x
14%
60%
23%
36%
$162K
US
0.1%
$106
+17%
$2B
7.9x
11%
72%
32%
29%
44%
$376K
CN
0.1%
$6
$2B
JP
0.1%
$10
+88%
$2B
4.0x
4%
57%
26%
9%
32%
$287K
TW
0.1%
$15
$2B
54.0x
$5K
CN
0.1%
$3
-8%
$2B
6.2x
7%
80%
39%
46%
SE
0.1%
$6
+13%
$2B
1.5x
3%
36%
20%
8%
19%
$414K

Explore More Indexes

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial